These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11849629

  • 1. The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
    Zieman M.
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S1-2. PubMed ID: 11849629
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic overview of Ortho Evra/Evra.
    Abrams LS, Skee D, Natarajan J, Wong FA.
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S3-12. PubMed ID: 11849630
    [Abstract] [Full Text] [Related]

  • 3. Evra--a patch on oral contraception?
    Drug Ther Bull; 2003 Dec; 41(12):89-91. PubMed ID: 14723093
    [Abstract] [Full Text] [Related]

  • 4. [A transdermal form of combined hormonal contraceptives (EVRA)].
    Fanta M.
    Ceska Gynekol; 2003 Oct; 68(5):341-5. PubMed ID: 14692356
    [Abstract] [Full Text] [Related]

  • 5. Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
    Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC.
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S27-31. PubMed ID: 11849633
    [Abstract] [Full Text] [Related]

  • 6. Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.
    Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW.
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S13-8. PubMed ID: 11849631
    [Abstract] [Full Text] [Related]

  • 7. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit.
    J Fam Plann Reprod Health Care; 2004 Jan; 30(1):43-5. PubMed ID: 15006313
    [Abstract] [Full Text] [Related]

  • 8. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
    Sibai BM, Odlind V, Meador ML, Shangold GA, Fisher AC, Creasy GW.
    Fertil Steril; 2002 Feb; 77(2 Suppl 2):S19-26. PubMed ID: 11849632
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise.
    Abrams LS, Skee DM, Natarajan J, Wong FA, Leese PT, Creasy GW, Shangold MM.
    J Clin Pharmacol; 2001 Dec; 41(12):1301-9. PubMed ID: 11762557
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
    Radowicki S, Skórzewska K, Szlendak K.
    Ginekol Pol; 2005 Nov; 76(11):884-9. PubMed ID: 16566363
    [Abstract] [Full Text] [Related]

  • 14. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
    Wooltorton E.
    CMAJ; 2006 Jan 17; 174(2):164-5. PubMed ID: 16368722
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
    Pierson RA, Archer DF, Moreau M, Shangold GA, Fisher AC, Creasy GW.
    Fertil Steril; 2003 Jul 17; 80(1):34-42. PubMed ID: 12849799
    [Abstract] [Full Text] [Related]

  • 17. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
    Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D.
    J Pediatr Adolesc Gynecol; 2005 Apr 17; 18(2):85-90. PubMed ID: 15897103
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.
    Abrams LS, Skee DM, Natarajan J, Wong FA, Anderson GD.
    Br J Clin Pharmacol; 2002 Feb 17; 53(2):141-6. PubMed ID: 11851637
    [Abstract] [Full Text] [Related]

  • 20. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR, Loomba PK.
    J Reprod Med; 2003 Jul 17; 48(7):525-40. PubMed ID: 12953327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.